emtricitabine was discovered by dr. dennis c. liotta, dr. raymond f. schinazi, and dr. woo-baeg choi of emory university and licensed to triangle pharmaceuticals by emory in 1996. triangle pharmaceuticals was acquired in 2003 by gilead sciences, who completed development and now market the product with the brand name "emtriva".